Statistical methods for predicting variceal hemorrhage.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 1537511)

Published in Gastroenterology on March 01, 1992

Authors

C Merkel, A Gatta

Articles cited by this

Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology (1991) 1.47

Articles by these authors

The tRNA genes punctuate the reading of genetic information in human mitochondrial DNA. Cell (1980) 2.53

Long term effect of alpha interferon in children with chronic hepatitis B. Gut (2000) 2.21

Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med (1991) 1.91

A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (1999) 1.74

Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology (1993) 1.69

Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial. Gut (2010) 1.65

Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med (1994) 1.65

Nutrition and survival in patients with liver cirrhosis. Nutrition (2001) 1.60

Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition (1997) 1.54

Spontaneous regression of hepatitis B virus-associated cirrhosis developed in childhood. Dig Liver Dis (2005) 1.51

Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. Hepatology (1996) 1.46

Fractionation of mitochondrial RNA from HeLa cells by high-resolution electrophoresis under strongly denaturing conditions. J Mol Biol (1978) 1.44

Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV. Neurology (2006) 1.42

Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol (1998) 1.39

Hypophosphatemia and renal tubular dysfunction in alcoholics. Are they related to liver function impairment? Gastroenterology (1991) 1.39

Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology (1999) 1.25

Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol (1996) 1.25

The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (2000) 1.24

Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology (2000) 1.24

Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis (2002) 1.18

Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr (1996) 1.16

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer (2004) 1.14

Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (2000) 1.13

Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology (1992) 1.10

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol (2001) 1.10

Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol (1999) 1.08

Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology (1994) 1.07

Fat emboli in bilateral total knee arthroplasty. Predictive factors for neurologic manifestations. Clin Orthop Relat Res (1989) 1.06

Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon. Gastroenterology (2000) 1.05

Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirrhosis. J Hepatol (1997) 1.04

The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology (1996) 1.04

Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci (1991) 1.04

Paraumbilical vein patency in cirrhosis: effects on hepatic hemodynamics evaluated by Doppler sonography. Hepatology (1995) 1.03

Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol (2000) 1.01

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut (2001) 1.01

Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE. J Clin Invest (1997) 1.00

Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology (1995) 0.99

Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders. Clin Nutr (2001) 0.99

Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Hepatology (1998) 0.99

Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler. Ultrasound Med Biol (2001) 0.98

Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. Hepatology (1996) 0.95

Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology (1995) 0.93

Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group. Hepatogastroenterology (2000) 0.92

Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes. Int J Biol Markers (2004) 0.92

Substrate availability other than glucose in the brain during euglycemia and insulin-induced hypoglycemia in dogs. Metabolism (1990) 0.91

Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment. J Hepatol (1998) 0.91

Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut (1992) 0.90

Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG. Metab Brain Dis (1996) 0.90

Neurological complications after orthotopic liver transplantation. Dig Liver Dis (2007) 0.89

Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. Aliment Pharmacol Ther (2006) 0.89

Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. Digestion (1985) 0.88

Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. Br J Clin Pharmacol (1986) 0.88

Thrombosis of the portal venous system. J Ultrasound (2007) 0.87

Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients. J Hepatol (1992) 0.87

Cirrhosis and muscle cramps: evidence of a causal relationship. Hepatology (1996) 0.86

Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement. Clin Physiol (1985) 0.86

Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation. Jpn Heart J (1998) 0.86

Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy. Metab Brain Dis (1998) 0.86

Visceral fistula as a complication of endoscopic treatment of esophageal and gastric varices using isobutyl-2-cyanoacrylate: report of two cases. Gastrointest Endosc (2000) 0.86

Neurocognitive-neurological complications of liver transplantation: a review. Metab Brain Dis (2010) 0.85

Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study. Am J Gastroenterol (1994) 0.84

Tissue plasminogen activator in cultured human trabecular meshwork cells. Predominance of enzyme over plasminogen activator inhibitor. Invest Ophthalmol Vis Sci (1988) 0.84

A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients. Hepatology (1991) 0.84

Arterioportal fistulas in patients with liver cirrhosis: usefulness of color Doppler US for screening. Radiology (2000) 0.84

Renal water and sodium handling in compensated liver cirrhosis: mechanism of the impaired natriuresis after saline loading. Eur J Clin Invest (1985) 0.84

Implication of pulse oxymetry screening for detection of congenital heart defects. Klin Padiatr (2010) 0.84

Visual attention in cirrhotic patients: a study on covert visual attention orienting. Hepatology (1998) 0.84

Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis. J Hepatol (1987) 0.83

Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP) Lancet (1997) 0.83

Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding. Am J Gastroenterol (1989) 0.83

The EEG assessment of low-grade hepatic encephalopathy: comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clin Neurophysiol (2006) 0.83

Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. Scand J Clin Lab Invest (1987) 0.83

Value of prealbumin plasma levels as liver test. Digestion (1987) 0.83